Cargando…

High Degree of Heterogeneity in Alzheimer's Disease Progression Patterns

There have been several reports on the varying rates of progression among Alzheimer's Disease (AD) patients; however, there has been no quantitative study of the amount of heterogeneity in AD. Obtaining a reliable quantitative measure of AD progression rates and their variances among the patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komarova, Natalia L., Thalhauser, Craig J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207941/ https://www.ncbi.nlm.nih.gov/pubmed/22072952 http://dx.doi.org/10.1371/journal.pcbi.1002251

Ejemplares similares

Calculating Stage Duration Statistics in Multistage Diseases
por: Komarova, Natalia L., et al.
Publicado: (2011)

Signal Response Sensitivity in the Yeast Mitogen-Activated Protein Kinase Cascade
por: Thalhauser, Craig J., et al.
Publicado: (2010)

Selection in spatial stochastic models of cancer: Migration as a key modulator of fitness
por: Thalhauser, Craig J, et al.
Publicado: (2010)

Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer’s Disease
por: Byun, Min Soo, et al.
Publicado: (2015)

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease
por: Keret, Ophir, et al.
Publicado: (2021)

Tumor-Immune Interaction, Surgical Treatment, and Cancer Recurrence in a Mathematical Model of Melanoma
por: Eikenberry, Steffen, et al.
Publicado: (2009)

Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
por: Jutten, Roos J., et al.
Publicado: (2021)

Decoding the heterogeneity of Alzheimer’s disease diagnosis and progression using multilayer networks
por: Avelar-Pereira, Bárbara, et al.
Publicado: (2022)

Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity
por: Iturria-Medina, Yasser, et al.
Publicado: (2022)

Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
por: Tatsuoka, Curtis, et al.
Publicado: (2013)

Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers
por: Goyal, Devendra, et al.
Publicado: (2018)

The heterogeneity within Alzheimer's disease
por: Ferreira, Daniel, et al.
Publicado: (2018)

Distinctive Pattern of Serum Elements During the Progression of Alzheimer’s Disease
por: Paglia, Giuseppe, et al.
Publicado: (2016)

Patterns of progressive atrophy vary with age in Alzheimer's disease patients
por: Fiford, Cassidy M., et al.
Publicado: (2018)

Heterogeneity in Alzheimer’s Disease and Related Dementias
por: Au, Rhoda
Publicado: (2019)

An optimal degree of physical and chemical heterogeneity for the origin of life?
por: Szostak, Jack W.
Publicado: (2011)

Impact of Degree Heterogeneity on Attack Vulnerability of Interdependent Networks
por: Sun, Shiwen, et al.
Publicado: (2016)

A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
por: McGhee, David J. M., et al.
Publicado: (2014)

Impact of degree heterogeneity on the behavior of trapping in Koch networks
por: Zhang, Zhongzhi, et al.
Publicado: (2010)

Heterogeneity in Preclinical Alzheimer’s Disease Trial Cohort Identified by Image-based Data-Driven Disease Progression Modelling
por: Shand, Cameron, et al.
Publicado: (2023)

Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease
por: Pan, Dan, et al.
Publicado: (2022)

Heterogeneity of Alzheimer’s disease identified by neuropsychological test profiling
por: Nguyen, Truc Tran Thanh, et al.
Publicado: (2023)

Back to the future: Alzheimer's disease heterogeneity revisited
por: Au, Rhoda, et al.
Publicado: (2015)

To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?
por: Caro, Jaime, et al.
Publicado: (2002)

Characteristics Scanning of Brain Structure and Function Changes in Patients with Different Degrees of Alzheimer's Disease
por: Zhang, Yamin, et al.
Publicado: (2022)

A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
por: Ermakov, Sergey, et al.
Publicado: (2019)

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
por: Ringman, John M., et al.
Publicado: (2014)

Patterns of Cerebellar Gray Matter Atrophy Across Alzheimer’s Disease Progression
por: Toniolo, Sofia, et al.
Publicado: (2018)

Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
por: Yokoyama, Jennifer S, et al.
Publicado: (2015)

The degree of intratumor mutational heterogeneity varies by primary tumor sub-site
por: Ledgerwood, Levi G., et al.
Publicado: (2016)

A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models
por: Ramanujan, Saroja, et al.
Publicado: (2019)

Predicting progression of Alzheimer's disease
por: Doody, Rachelle S, et al.
Publicado: (2010)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?
por: Devi, Gayatri, et al.
Publicado: (2018)

Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer’s disease
por: Corriveau-Lecavalier, Nick, et al.
Publicado: (2023)

Brain atrophy rates in first degree relatives at risk for Alzheimer's
por: Lampert, Erika J., et al.
Publicado: (2014)

The Value of an Incomplete Degree: Heterogeneity in the Labor Market Benefits of College Non-Completion
por: Giani, Matt S., et al.
Publicado: (2019)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
por: Josephs, Keith A., et al.
Publicado: (2020)

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
por: El Hajj, Hassan, et al.
Publicado: (2019)

Metabolome in progression to Alzheimer's disease
por: Orešič, M, et al.
Publicado: (2011)

Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
por: Umeda-Kameyama, Yumi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7tc2526k91pah8b20bd4oo3m1c